Vaccinex, Inc.
VCNX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001205922
No open-market purchases or sales by Vaccinex, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Vaccinex, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −2 vs. Q3 2021
- Shares held
- 1.60M
- +42.0K (+2.7%) vs. Q3 2021
- Total value
- $1.66M
- −$1.70M (−50.6%) vs. Q3 2021
- New holders
- 2
- 5 more added
- Sold out
- 4
- 4 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VCNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $45 |
| Q3 2024 | 12 | $1.14M |
| Q2 2024 | 11 | $1.81M |
| Q1 2024 | 12 | $2.39M |
| Q4 2023 | 18 | $1.07M |
| Q3 2023 | 19 | $2.92M |
| Q2 2023 | 23 | $994.8K |
| Q1 2023 | 24 | $1.10M |
| Q4 2022 | 25 | $3.12M |
| Q3 2022 | 22 | $2.28M |
| Q2 2022 | 27 | $5.03M |
| Q1 2022 | 25 | $5.49M |
| Q4 2021 | 21 | $1.66M |
| Q3 2021 | 23 | $3.36M |
| Q2 2021 | 28 | $4.54M |
| Q1 2021 | 33 | $2.79M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Vaccinex, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 182 | $0 | 0.00% | −5,431−96.8% | Reduced |
| Morgan Stanley | 300 | $0 | 0.00% | −201−40.1% | Reduced |
| Wells Fargo & Company | 110 | $0 | 0.00% | +9+8.9% | Added |
| Group One Trading, L.P. | 1,189 | $1.00K | 0.00% | +1,189 | New |
| Ancora Advisors, LLC | 2,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,273 | $3.00K | 0.00% | +749+29.7% | Added |
| Vectors Research Management, LLC | 5,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 4,300 | $5.00K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 5,655 | $5.00K | 0.00% | +3,330+143.2% | Added |
| Creative Planning | 11,000 | $11.0K | 0.00% | 00.0% | Unchanged |
| Oppenheimer & Co Inc | 14,351 | $15.0K | 0.00% | −17,400−54.8% | Reduced |
| Northern Trust Corp | 16,702 | $17.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 22,036 | $23.0K | 0.00% | −8,172−27.1% | Reduced |
| Natixis | 31,895 | $33.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 49,716 | $52.0K | 0.00% | +1,220+2.5% | Added |
| State Street Corp | 67,800 | $71.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 81,424 | $86.0K | 0.00% | +81,424 | New |
| Geode Capital Management, LLC | 128,332 | $134.0K | 0.00% | 00.0% | Unchanged |
| Telemetry Investments, L.L.C. | 133,000 | $138.0K | 0.18% | +500+0.4% | Added |
| Point72 Asset Management, L.P. | 395,522 | $411.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 623,182 | $648.0K | 0.00% | 00.0% | Unchanged |
| Tacita Capital Inc | 0 | $0 | 0.00% | −13,574−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Bedel Financial Consulting, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |